Tessella Biosciences develops ready-to-use bioinks and biopolymers designed for 3D bioprinting, featuring high printability and tunable mechanical properties for accurate tissue modeling. Their products enhance cell viability and enable the printing of complex structures, addressing the challenges of reproducibility and performance in bioprinting applications.
Funding
Funding not disclosed
Founders
Product
Problem
Reproducibility and performance challenges in 3D bioprinting hinder accurate tissue modeling and the creation of complex biological structures. Existing bioinks often lack the necessary printability, cell viability, and tunable mechanical properties required for consistent and successful bioprinting outcomes.
Solution
Tessella Biosciences develops and provides ready-to-use bioinks and biopolymers specifically designed to enhance 3D bioprinting processes. Their products offer high printability and cell viability, enabling researchers to create robust and reproducible printed constructs. The bioinks and biopolymers also allow for the creation of complex structures with tunable mechanical properties, addressing key limitations in bioprinting applications.
Target Audience
The primary customers are researchers and scientists in the fields of tissue engineering, regenerative medicine, and bioprinting who require reliable and high-performance bioinks and biopolymers for their experiments.
Features
- High printability for smooth and reliable 3D bioprinting.
- Enhanced cell viability to support cell growth and function within printed structures.
- Tunable mechanical properties for creating constructs with specific physical characteristics.
- Robust and reproducible printing performance for consistent results.
- Optimized for printing complex biological structures.